Holdings of Tetragon Partners GP Ltd
30 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 86.1 % of the equity sleeve
Sector breakdown
- Communication 5.6 %
- Industrials 0.7 %
- Technology 0.3 %
- Unattributed 93.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 28 | 439.3M $ | 96.39 % |
| 2 | GB | 2 | 16.4M $ | 3.61 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | UiPath Inc | 25,207,628 | 279.8M $ | |
| 2 | Warner Bros Discovery Inc | 923,725 | 25.4M $ | |
| 3 | Workiva Inc | 250,000 | 14.9M $ | |
| 4 | Lyft Inc | 1,000,000 | 13.3M $ | |
| 5 | Sprinklr Inc | 2,200,000 | 13.2M $ | |
| 6 | Autolus Therapeutics PLC | 9,500,000 | 13.1M $ | |
| 7 | Celldex Therapeutics Inc | 312,316 | 9.9M $ | |
| 8 | Arrowhead Pharmaceuticals Inc | 127,198 | 8M $ | |
| 9 | Nektar Therapeutics | 103,037 | 7.4M $ | |
| 10 | Annexon Inc | 1,292,455 | 7.2M $ | |
| 11 | Agios Pharmaceuticals Inc | 164,839 | 5.6M $ | |
| 12 | Immunovant Inc | 218,507 | 5.4M $ | |
| 13 | Praxis Precision Medicines Inc | 15,952 | 5.1M $ | |
| 14 | Krystal Biotech Inc | 19,668 | 5.1M $ | |
| 15 | Dyne Therapeutics Inc | 258,132 | 4.7M $ | |
| 16 | Amylyx Pharmaceuticals Inc | 317,877 | 4.4M $ | |
| 17 | MBX Biosciences Inc | 145,480 | 4.3M $ | |
| 18 | Soleno Therapeutics Inc | 102,125 | 3.4M $ | |
| 19 | Axsome Therapeutics Inc | 20,059 | 3.4M $ | |
| 20 | Harmony Biosciences Holdings Inc | 119,340 | 3.3M $ | |
| 21 | Silence Therapeutics PLC | 630,161 | 3.3M $ | |
| 22 | ACADIA Pharmaceuticals Inc | 144,620 | 3.2M $ | |
| 23 | Ionis Pharmaceuticals Inc | 41,764 | 3.1M $ | |
| 24 | MapLight Therapeutics Inc | 112,115 | 2.3M $ | |
| 25 | Relay Therapeutics Inc | 181,543 | 1.8M $ | |
| 26 | Snowflake Inc | 10,000 | 1.5M $ | |
| 27 | Aardvark Therapeutics Inc | 316,621 | 1.2M $ | |
| 28 | Tectonic Therapeutic Inc | 37,588 | 1.2M $ | |
| 29 | Ultragenyx Pharmaceutical Inc | 39,473 | 827K $ | |
| 30 | Karyopharm Therapeutics Inc | 52,984 | 295.1K $ | |